3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
19
Lung Neoplasms
18
Breast Neoplasms
12
Multiple Myeloma
10
Carcinoma, Non-Small-Cell Lung
9
Leukemia, Myeloid, Acute
8
Rectal Neoplasms
7
Carcinoma, Hepatocellular
7
Myelodysplastic Syndromes
6
Mouth Neoplasms
6
Sarcoma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Pancreatic Neoplasms
5
Oropharyngeal Neoplasms
5
Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
5
Leukemia, Myelomonocytic, Chronic
5
Head and Neck Neoplasms
5
Brain Neoplasms
5
Ovarian Neoplasms
4
Melanoma
4
Lymphoma, B-Cell
4
Leukemia, Biphenotypic, Acute
4
Glioma
4
Fallopian Tube Neoplasms
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Lymphoma, T-Cell
3
Lymphoma, Non-Hodgkin
3
Laryngeal Neoplasms
3
Interventions
pembrolizumab
4
Trastuzumab
4
Oxaliplatin
4
Fluorouracil
4
Cyclophosphamide
4
Carboplatin
4
Radiotherapy
3
Paclitaxel
3
Endoscopy
3
Docetaxel
3
Cytarabine
3
Chemoradiotherapy
3
Capecitabine
3
toripalimab
2
Tretinoin
2
Surgical Procedures, Operative
2
Standard of Care
2
Observation
2
Neoadjuvant Therapy
2
Metformin
2
Magnetic Resonance Imaging
2
Leucovorin
2
Irinotecan
2
Immunotherapy
2
Immune Checkpoint Inhibitors
2
Epirubicin
2
Drug Therapy
2
Doxorubicin
2
Cisplatin
2
Blood Specimen Collection
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pathologic Complete Response
×
X-Rays
×
Clear all
NCT02233374
2022-10-28
PRISM
Royal North Shore Hospital
Phase NA
Completed
27 enrolled